Reverse docking: A powerful tool for drug repositioning and drug rescue

Future Medicinal Chemistry

Volumn 6, Issue 3, 2014, Pages 333-342

  Kharkar, Prashant S ^a   Warrier, Sona ^a   Gaud, Ram S ^a  

^a Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; LEUKOTRIENE A4 HYDROLASE; LIGAND; PROTEIN SERINE KINASE; PROTEIN TYROSINE KINASE;

COMPETITIVE INHIBITION; CYTOTOXICITY; DRUG BINDING SITE; DRUG REPOSITIONING; DRUG RESCUE; ENZYME INHIBITION; EXPERIMENTAL THERAPY; HIGH THROUGHPUT SCREENING; HUMAN; MOLECULAR DOCKING; NONHUMAN; PHARMACEUTICAL CARE; PHARMACOPHORE; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; PRODUCTIVITY; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SYSTEMATIC REVIEW;

ANIMALS; DATABASES, FACTUAL; DRUG DISCOVERY; DRUG REPOSITIONING; HUMANS; MOLECULAR DOCKING SIMULATION; SOFTWARE;

EID: 84895442722     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.207     Document Type: Review

References (47)

1. Pammolli F, Magazzini M, Riccaboni M. The productivity crisis in pharmaceutical R&D. Nat. Rev. Drug Discov. 10(6), 428-438 (2011).
2. Ashburn TT, Thor KB. Drug repositioning: Identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3(8), 673-683 (2004).
3. Liu Z, Fang H, Reagan K et al. In silico drug repositioning-what we need to know. Drug Discov. Today 18(3-4), 110-115 (2013).
4. Hurle MR, Yang L, Xie Q, Rajpal DK, Sanseau P, Agarwal P. Computational drug repositioning: From data to therapeutics. Clin. Pharmacol. Ther. 93(4), 335-341 (2013).
5. Cheng T, Li Q, Zhou Z, Wang Y, Bryant SH. Structure-based virtual screening for drug discovery: A problem-centric review. AAPS J. 14(1), 133-141 (2012).
6. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat. Rev. Drug Discov. 3(11), 935-949 (2004).
7. Bhattacharjee B, Chatterjee J. Identification of proapoptopic, anti-inflammatory, anti-proliferative, anti-invasive and anti-Angiogenic targets of essential oils in cardamom by dual reverse virtual screening and binding pose analysis. Asian Pac. J. Cancer Prev. 14(6), 3735-3742 (2013).
8. Kinnings SL, Jackson RM. ReverseScreen3D: A structure-based ligand matching method to identify protein targets. J. Chem. Inf. Model. 51(3), 624-634 (2011).
9. Liu X, Ouyang S, Yu B et al. PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res. 38, W609-W614 (2010).
10. Knox C, Law V, Jewison T et al. DrugBank 3.0: A comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 39(D1), D1035-D1041 (2011).
11. Gao Z, Li H, Zhang H et al. PDTD: A web-Accessible protein database for drug target identification. BMC Bioinformatics 9, 104 (2008).
12. Li H, Gao Z, Kang L et al. TarFisDock: A web server for identifying drug targets with docking approach. Nucl. Acids Res. 34, W219-W224 (2006).
13. Crowther GJ, Shanmugam D, Carmona SJ et al. Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl. Trop. Dis. 4(8), e804 (2010).
14. Zhu F, Shi Z, Qin C et al. Therapeutic target database update 2012: A resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 40(D1), D1128-D1136 (2012).
15. Kellenberger E, Muller P, Schalon C, Bret G, Foata N, Rognan D. sc-PDB: An Annotated database of druggable binding sites from the protein data bank. J. Chem. Inf. Model. 46(2), 717-727 (2006).
16. Hopkins AL, Groom CR. The druggable genome. Nat. Rev. Drug Discov. 1(9), 727-730 (2002).
17. Huang SY, Zou X. An iterative knowledge-based scoring function to predict protein-ligand interactions: I. derivation of the interaction potentials. J. Comput. Chem. 27(15), 1866-1875 (2006).
18. Grinter SZ, Liang Y, Huang S-Y, Hyder SM, Zou X. An inverse docking approach for identifying new potential anti-cancer targets. J. Mol. Graph. Model. 29(6), 795-799 (2011).
19. Chen YZ, Zhi DG. Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins 43(2), 217-226 (2001).
20. Chen YZ, Ung CY. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. J. Mol. Graph. Mod. 20(3), 199-218 (2001).
21. Chen YZ, Ung CY. Computer automated prediction of putative therapeutic and toxicity protein targets of bioactive compounds from chinese medicinal plants. Am. J. Chin. Med. 30(1), 139-154 (2002).
22. Ellingson SR, Smith JC, Baudry J. VinaMPI: Facilitating multiple receptor high-Throughput virtual docking on high-performance computers. J. Comput. Chem. 34(25), 2212-2221 (2013).
23. Morris GM, Huey R, Lindstrom W et al. Autodock4 and AutoDockTools4: Automated docking with selective receptor flexiblity. J. Comp. Chem. 30(16), 2785-2791 (2009).
24. Zheng R, Chen T, Lu T. A comparative reverse docking strategy to identify potential antineoplastic targets of tea functional components and binding mode. Int. J. Mol. Sci. 12(8), 5200-5212 (2011).
25. Erić S, Ke S, Barata T, et al. Target fishing and docking studies of the novel derivatives of arylaminopyridines with potential anticancer activity. Bioorg. Med. Chem. 20(17), 5220-5228 (2012).
26. Cai J, Han C, Hu T et al. Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: Reverse docking, enzymatic assay, and x-ray crystallography validation. Protein Sci. 15(9), 2071-2081 (2006).
27. Lauro G, Masullo M, Piacente S, Riccio R, Bifulco G. Inverse virtual screening allows the discovery of the biological activity of natural compounds. Bioorg. Med. Chem. 20(11), 3596-3602 (2012).
28. Kellenberger E, Foata N, Rognan D. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: Methods and problems. J. Chem. Inf. Model. 48(5), 1014-1025 (2008).
29. Muller P, Lena G, Boilard E et al In silico-guided target identification of a scaffold-focused library: 1,3,5-Triazepan-2,6-diones as novel phospholipase A2 inhibitors. J. Med. Chem. 49(23), 6768-6778 (2006).
30. Lamb ML, Burdick KW, Toba S et al. Design, docking, and evaluation of multiple libraries against multiple targets. Proteins 42(3), 296-318 (2001).
31. Schapira M, Abagyan R, Totrov M. Nuclear hormone receptor targeted virtual screening. J. Med. Chem. 46(14), 3045-3059 (2003).
32. Paul N, Kellenberger E, Bret G, Müller P, Rognan, D. Recovering the true targets of specific ligands by virtual screening of the protein data bank. Proteins 54(4), 671-680 (2004).
33. Fan S, Geng Q, Pan Z et al. Clarifying off-Target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Syst. Biol. 6, 152 (2012).
34. Zahler S, Tietze S, Totzke F et al. Inverse in silico screening for identification of kinase inhibitor targets. Chem. Biol. 14(11), 1207-1214 (2007).
35. Lee M, Kim D. Large-scale reverse docking profiles and their applications. BMC Bioinformatics 13(Suppl. 17), S6 (2012).
36. Krasowski A, Muthas D, Sarkar A, Schmitt S, Brenk R. DrugPred: A structure-based approach to predict protein druggability developed using an extensive nonredundant data set. J. Chem. Inf. Model. 51(11), 2829-2842 (2011).
37. Karlin S, Altschul SF. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc. Natl Acad. Sci. USA 87(6), 2264-2268 (1990).
38. Liu TL, Xie HZ, Wei YQ, Yang SY. The feasibility of application of reverse docking method to the selectivity studies of protein kinase inhibitors. Yao. Xue. Xue. Bao. 44(7), 758-763 (2009).
39. Ghersi D, Sanchez R. Improving accuracy and efficiency of blind protein-ligand docking by focusing on predicted binding sites. Proteins 74(2), 417-424 (2009).
40. Le Guilloux V, Schmidtke P, Tuffery P. Fpocket: An open source platform for ligand pocket detection. BMC Bioinformatics 10, 168 (2009).
41. O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. J. Cheminform. 3, 33 (2011).
42. Warren GL, Andrews CW, Capelli A-M et al. A critical assessment of docking programs and scoring functions. J. Med. Chem. 49(20), 5912-5931 (2006).
43. Huang SY, Grinter SZ, Zou X. Scoring functions for protein-ligand docking: Recent advances and future directions. Phys. Chem. Chem. Phys. 12(40), 12899-12908 (2010).
44. Wang JC, Chu PY, Chen CM, Lin JH. idTarget: A web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-And-conquer docking approach. Nucleic Acids Res. 40, W393-W399 (2012).
45. Huang N, Stoichet BK, Irwin JJ. Benchmarking sets for molecular docking. J. Med. Chem. 49(23), 6789-6801 (2006).
46. Spitzer R, Jain AN. Surflex-Dock: Docking benchmarks and real-world application. J. Comput. Aided Mol. Des. 26(6), 687-699 (2012).
47. Hui-fang L, Qing S, Jian Z, Wei F. Evaluation of various inverse docking schemes in multiple target identification. J. Mol. Graph. Model. 29(3), 326-330 (2010).